Daiwa Pharmaceutical Co., Ltd (Daiwa), held the “NKCP Workshop 2013” at the Tokyo International Forum on January 27, 2013. Clinicians from not only Japan, but also overseas, including USA and Philippines, were invited to this meeting to give presentations and panel discussions.

The meeting was very productive because of the clinicians’ presentations on accumulated clinical data and examples, resulting in an animated discussion on the material.

NKCP has been on the market in twenty-one countries all over the world, mainly in Asia, North America, and Europe. This product has been granted an international patent in seven countries for its ability to reduce blood viscosity. Daiwa will continue promotional activity by offering the latest information on this product in domestic and overseas markets.

1. “Basic and clinical efficacy of NKCP”
Masahito Hitosugi, M.D., Ph.D.
Associate professor, Department of Legal Medicine,
Dokkyo Medical University School of Medicine, Tochigi, Japan

2. “Clinical report of NKCP and glucosamine sulfate on osteoarthritis”
Kenichi Ichihashi, M.D., Ph.D., Ichihashi Clinic, Kobe, Japan

3. “Battleground against heart disease: Watch and follow your blood coagulation”
Raif Tawakol, M.D., Cardiovascular Surgeon,
Cardiovascular Clinic of California, President, USA

4. “Clinical report of NKCP in the clinic in Philippines”
Edna Sasing Lao, M.D., Dr. Edna Sasing Lao Clinic, Philippines

5. Report on clinical examples by the presenters/Panel discussions

6. Q&A